ELTROMBOPAG: A MEDICAL COUNTERMEASURE TO MITIGATE THROMBOCYTOPENIA FOLLOWING MYELOSUPPRESSIVE DOSES OF RADIATIONSEE STATEMENT OF WORK FOR MORE DETAILSIGF::OT::IGF
$37,716,044
| Recipient | NOVARTIS PHARMACEUTICALS CORPORATION UEI NG61ZA8TADW3 |
|---|---|
| Award ID | HHSO100201700026C |
| Award amount | $37,716,044 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response |
| NAICS | 541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY |
| PSC | AN92 |
| Start date | Sep 14, 2017 |
| End date | Jun 30, 2024 |
| Place of performance | EAST HANOVER, NJ |
| Record updated | Apr 13, 2022 |
View the official award record
More awards won by NOVARTIS PHARMACEUTICALS CORPORATION
BPA FOR KYMRIAH, FABHALTA, NETSPOT, AND LOCAMETZ
Department of Veterans Affairs · $61,084,060 · Oct 2, 2025
PLUVICTO
Department of Veterans Affairs · $7,480,000 · Oct 1, 2025
BPA FOR PLUVICTO AND LUTATHERA INJECTION
Department of Defense · $5,000,000 · Mar 2, 2026
PLUVICTO
Department of Veterans Affairs · $4,732,608 · Feb 24, 2026
LU177 - PLUVICTO/LUTATHERA
Department of Veterans Affairs · $4,162,659 · Feb 7, 2026
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids